Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

The Lancet

Volumn 343, Issue 8908, 1994, Pages 1255-1258

  Finkel, T H ^a   Leung, D Y M ^a   Harbeck, R J ^a   Gelfand, E W ^a   Torok T J ^b   Zaki, S R ^b   Anderson, Lj ^b   Ferguson, P J ^c   Saulsbury, F T ^c   Durigon, E L ^d   Hollister, J R ^e  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN;

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NECROTIZING ARTERITIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; WEGENER GRANULOMATOSIS;

EID: 0028365617     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)92152-0     Document Type: Article

References (27)

1. Parvovirus B19 and human disease
2. Fifth disease: the frequency of joint involvement in adults
3. Hematologic and hematopoietic consequences of B19 parvovirus infection
4. Human parvovirus B19 and pregnancy
5. Persistent parvovirus B19 infections in humans
6. Polyarteritis nodosa and parvovirus B19 infection
7. Henoch-Schönlein purpura and human parvovirus infection
8. Parvovirus B19 and necrotising vasculitis
9. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum
10. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunologically similar to native virus
11. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
12. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
13. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments
14. Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reaction
15. Experimental parvoviral infection in humans
16. Parvovirus infection after renal transplant
17. Pure red cell aplasia induced by B19 parvovirus during allogeneic bone marrow transplantation
18. Immune response to B19 parvovirus and an antibody defect in persistent viral infection
19. Chronic parvovirus infection in a presumably immunologically healthy woman
20. Pathogenesis of systemic vasculitis
21. Monoclonal-antibody therapy in systemic vasculitis
22. Treatment of systemic vasculitis with pooled intravenous immunoglobulin
23. Erythrocyte P antigen: cellular receptor for B19 parvovirus
24. Clinical and histopathological features of parvovirus B19 infection in the human fetus
25. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection
26. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS